Cancer clinical trials in the region Hauts-de-France
105 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
#NCT05325866
HER2 Negative
HR Negative
Locally Advanced
Metastatic
FGFR
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Colon cancer
Rectal cancer
#NCT04730544
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Universitaire de Lille (Lille) (and 9 more...)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Lymphoma
#NCT04663347
B cell lymphoma
Follicular lymphoma
CD20
None
Immunotherapy
Chemotherapy
Targeted therapy
1
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Hôpital de la Timone AP-HM (Marseille), Hôpital Saint Louis AP-HP (Paris), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Claude Huriez (Lille)
Genmab
Phase 2
Lymphoma
#NCT04446962
B cell lymphoma
Primary cerebral lymphoma
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), Centre Henri Becquerel (Rouen ), Centre Hospitalier de Colmar (Colmar) (and 17 more...)
Institut Curie
Phase 2
Lung cancer
#NCT04400539
Mesothelium
Chemotherapy
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
Phase 2
Kidney cancer
#NCT04299646
Clear cell carcinoma
Metastatic
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
0
1 or 2
Centre François Baclesse (Caen ), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Gustave Roussy (Villejuif), Centre Oscar Lambret (Lille)
Centre François Baclesse
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
Neuroendocrine tumor
Localized
CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Toulouse (Toulouse), CHU Amiens-Picardie (site sud) (Amiens), Centre Hospitalier Universitaire de Besançon (Besançon) (and 4 more...)
Phase 2
Breast cancer
#NCT04143711
HER2 Low
HER2 Positive
Locally Advanced
Metastatic
Targeted therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Breast cancer
#NCT04143711
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics